Table 1.
Acute phase (first 4 weeks from infection) | Chronic phase (after 4 weeks) | |
---|---|---|
Symptoms |
• Nasopharyngeal (sore throat, runny nose) • Respiratory (cough, dyspnea) • Systemic (fever, headache, fatigue) |
• Respiratory (persistent cough, dyspnea, hypoxia) • Cardiovascular (palpitation, chest pain) • Neurological (headache, dizziness, numbness) • Neuropsychiatric (short-term memory loss, inability to concentrate, depression, anxiety) • Systemic (fatigue, muscular weakness, insomnia) |
Known mechanisms |
• Viral attack • Inflammatory response • Cytokine storm |
• Immune response • Chronic inflammation • Pulmonary fibrosis • Coagulopathy |
Treatment targets |
• Anti-viral medications • Immunomodulatory agents (cytokine inhibitors, immune globulin) |
• Supportive management • Rehabilitation • Vaccination • Anti-coagulation |